it shows the potential of neurobiologically-based drugs for the treatment of Rett syndrome and other neurodevelopmental disorders
we need to study autism next great opportunity for major benefit
Ann: Trofinetide significant clinical benefit in Rett syndrome, page-33
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
-0.220(1.41%) |
Mkt cap ! $1.991B | |||
| Open | High | Low | Value | Volume |
| $15.83 | $15.87 | $15.37 | $2.871M | 183.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1950 | $15.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.41 | 199 | 7 |
View Market Depth
| Last trade - 12.42pm 16/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |